loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 2243562 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 HYDROMORPHONE HYDROCHLORIDE (1)

filter

01 PURDUE PHARMA (1)

filter

01 CAPSULE (SUSTAINED-RELEASE) (1)

filter

01 18MG (1)

filter

01 Canada (1)

URL Supplier Web Content
CAPSULE (SUSTAINED-REL...
18MG
HYDROMORPH CONTIN-CONT...
Canada
2243562
50
Narcotic (CDSA I)
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2243562

Looking for CTD TGA MCC DOSSIER APPLICATION 2243562 1

19

Purdue Pharma, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is HYDROMORPHONE HYDROCHLORIDE, with a corresponding application number 2243562 and regulatory information .

proudly manufactured in the

Purdue Pharma's HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG CAPSULE (SUSTAINED-RELEASE), medication with 18MG of HYDROMORPHONE HYDROCHLORIDE.

Post Enquiry
POST ENQUIRY